These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11712177)

  • 21. Characterization of soluble polymerized fibrin formed in the presence of excess fibrinogen fragment D.
    Knoll D; Hantgan R; Williams J; McDonagh J; Hermans J
    Biochemistry; 1984 Jul; 23(16):3708-15. PubMed ID: 6236846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis of the fibrinogen-fibrin transformation: contributions from X-ray crystallography.
    Doolittle RF
    Blood Rev; 2003 Mar; 17(1):33-41. PubMed ID: 12490209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrodynamic and mass spectrometry analysis of nearly-intact human fibrinogen, chicken fibrinogen, and of a substantially monodisperse human fibrinogen fragment X.
    Cardinali B; Profumo A; Aprile A; Byron O; Morris G; Harding SE; Stafford WF; Rocco M
    Arch Biochem Biophys; 2010 Jan; 493(2):157-68. PubMed ID: 19853574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Some notes on crystallizing fibrinogen and fibrin fragments.
    Doolittle RF
    Biophys Chem; 2003; 100(1-3):307-13. PubMed ID: 12646373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragment E of fibrin as a fibrinogen cofactor in the reaction of enzymatic cross-linking.
    Leonova VB; Rozenfeld MA; Biryukova MI; Kostanova EA; Vasil'eva MV
    Dokl Biochem Biophys; 2002; 382():22-5. PubMed ID: 11938663
    [No Abstract]   [Full Text] [Related]  

  • 26. Fibrinogen and its derivatives: cofactors in the intrinsic generation of thrombin.
    Triantaphyllopoulos DC; Ryan LT
    Thromb Haemost; 1976 Apr; 35(2):305-13. PubMed ID: 989630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structures of fragments D and double-D from fibrinogen and fibrin.
    Doolittle RF; Spraggon G; Everse SJ
    Thromb Haemost; 1999 Aug; 82(2):271-6. PubMed ID: 10605713
    [No Abstract]   [Full Text] [Related]  

  • 28. [Thrombus formation with special reference to the substrates, fibrinogen and its related substances].
    Matsuda M
    Rinsho Ketsueki; 1984 Jul; 25(7):984-91. PubMed ID: 6502959
    [No Abstract]   [Full Text] [Related]  

  • 29. [Process of complexation of prothrombine and fibrin E-fragment].
    Savchuk OM; Krasnobryzha IeM; Horchev VF; Chernyshenko TM; Havryliuk SP; Platonova TM
    Ukr Biokhim Zh (1999); 2006; 78(3):99-105. PubMed ID: 17100316
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Self-assembly of soluble X-oligomers].
    Rozenfel'd MA; Kostanova EA; Vasil'eva MV; Leonova VB
    Dokl Akad Nauk; 1999 Apr; 365(4):551-3. PubMed ID: 10368763
    [No Abstract]   [Full Text] [Related]  

  • 31. The Structural-Functional Damage of Fibrinogen Oxidized by Hydrogen Peroxide.
    Yurina LV; Vasilyeva AD; Kononenko VL; Bugrova AE; Indeykina MI; Kononikhin AS; Nikolaev EN; Rosenfeld MA
    Dokl Biochem Biophys; 2020 May; 492(1):130-134. PubMed ID: 32632589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
    Lane DA; Preston FE; VanRoss ME; Kakkar VV
    Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional analysis of the fibrinogen Aalpha Thr312Ala polymorphism: effects on fibrin structure and function.
    Standeven KF; Grant PJ; Carter AM; Scheiner T; Weisel JW; Ariëns RA
    Circulation; 2003 May; 107(18):2326-30. PubMed ID: 12707238
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the fibrin polymer structure that accelerates thrombin cleavage of plasma factor XIII.
    Greenberg CS; Achyuthan KE; Rajagopalan S; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):142-8. PubMed ID: 2895608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanism of enzymatic crosslinking of fibrinogen molecules].
    Rozenfel'd MA; Leonova VB; Konstantinova ML; Razumovskiĭ SD
    Izv Akad Nauk Ser Biol; 2008; (6):671-9. PubMed ID: 19198072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and functional characterization of proteolytic fragments derived from the C-terminal regions of bovine fibrinogen.
    Litvinovich SV; Henschen AH; Krieglstein KG; Ingham KC; Medved LV
    Eur J Biochem; 1995 May; 229(3):605-14. PubMed ID: 7758453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fibrin and fibrinogen proteolysis products: comparison between gel filtration and SDS polyacrylamide electrophoresis analysis.
    Alkjaersig N; Davies A; Fletcher A
    Thromb Haemost; 1977 Aug; 38(2):524-5. PubMed ID: 145666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystallization of fragment D from human fibrinogen.
    Everse SJ; Pelletier H; Doolittle RF
    Protein Sci; 1995 May; 4(5):1013-6. PubMed ID: 7663337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological properties of fibrinogen derivatives relevant to the function of cardiovascular system and immuno-inflammatory reaction.
    Kopec M
    New Istanbul Contrib Clin Sci; 1977 Sep; 12(1):43-9. PubMed ID: 565049
    [No Abstract]   [Full Text] [Related]  

  • 40. Anticoagulant properties of purified X-like fragments of human fibrinogen produced by degradation with leukocyte elastase.
    Sterrenberg L; van Liempt GJ; Nieuwenhuizen W; Hermans J
    Thromb Haemost; 1984 Jul; 51(3):398-402. PubMed ID: 6238443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.